Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Plasma miR-34a-5p and miR-545-3p as Early Biomarkers of Alzheimer’s Disease: Potential and Limitations
Marta Cosín‐Tomás, Anna Antonell, Albert Lladó, et al.
Molecular Neurobiology (2016) Vol. 54, Iss. 7, pp. 5550-5562
Closed Access | Times Cited: 138

Showing 1-25 of 138 citing articles:

A rigorous method to enrich for exosomes from brain tissue
Laura J. Vella, Benjamin J. Scicluna, Lesley Cheng, et al.
Journal of Extracellular Vesicles (2017) Vol. 6, Iss. 1
Open Access | Times Cited: 263
Circulating microRNAs as potential biomarkers for psychiatric and neurodegenerative disorders
Merel M.J. van den Berg, Julian Krauskopf, Johannes G. Ramaekers, et al.
Progress in Neurobiology (2019) Vol. 185, pp. 101732-101732
Open Access | Times Cited: 208
Advances in the development of new biomarkers for Alzheimer’s disease
Timofey O. Klyucherev, Pawel K. Olszewski, Alena A. Shalimova, et al.
Translational Neurodegeneration (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 161
Epigenetics of Alzheimer’s Disease
Matea Nikolac Perković, Alja Videtič Paska, Marcela Konjevod, et al.
Biomolecules (2021) Vol. 11, Iss. 2, pp. 195-195
Open Access | Times Cited: 130
Blood-Based Biomarkers for Alzheimer’s Disease Diagnosis and Progression: An Overview
Angelica Varesi, Adelaide Carrara, Vitor Gomes Pires, et al.
Cells (2022) Vol. 11, Iss. 8, pp. 1367-1367
Open Access | Times Cited: 79
MicroRNA (miRNA) as a biomarker for diagnosis, prognosis, and therapeutics molecules in neurodegenerative disease
Zahraa Alkhazaali-Ali, Sajad Sahab-Negah, Amir Reza Boroumand, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 177, pp. 116899-116899
Open Access | Times Cited: 17
MicroRNA Profile in Patients with Alzheimer’s Disease: Analysis of miR-9-5p and miR-598 in Raw and Exosome Enriched Cerebrospinal Fluid Samples
Javier Riancho, José Luis Vázquez‐Higuera, Ana Pozueta, et al.
Journal of Alzheimer s Disease (2017) Vol. 57, Iss. 2, pp. 483-491
Closed Access | Times Cited: 141
Profile of 6 microRNA in blood plasma distinguish early stage Alzheimer’s disease patients from non-demented subjects
Siranjeevi Nagaraj, Katarzyna Laskowska-Kaszub, Konrad J. Dębski, et al.
Oncotarget (2017) Vol. 8, Iss. 10, pp. 16122-16143
Open Access | Times Cited: 137
MicroRNAs in Alzheimer’s Disease: Diagnostic Markers or Therapeutic Agents?
Francesco Angelucci, Kateřina Čechová, Martin Vališ, et al.
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 128
microRNA diagnostic panel for Alzheimer’s disease and epigenetic trade-off between neurodegeneration and cancer
Siranjeevi Nagaraj, Katarzyna Marta Zoltowska, Katarzyna Laskowska-Kaszub, et al.
Ageing Research Reviews (2018) Vol. 49, pp. 125-143
Open Access | Times Cited: 108
Biomarkers for Alzheimer’s Disease Early Diagnosis
Eva Ausó, Violeta Gómez‐Vicente, Gema Esquiva
Journal of Personalized Medicine (2020) Vol. 10, Iss. 3, pp. 114-114
Open Access | Times Cited: 108
Altered microRNAs related to synaptic function as potential plasma biomarkers for Alzheimer’s disease
Dolores Siedlecki‐Wullich, Judit Català-Solsona, Cristina Fábregas, et al.
Alzheimer s Research & Therapy (2019) Vol. 11, Iss. 1
Open Access | Times Cited: 104
Meta‐analyses identify differentially expressed microRNAs in Parkinson's disease
Jessica Schulz, Petros Takousis, Inken Wohlers, et al.
Annals of Neurology (2019) Vol. 85, Iss. 6, pp. 835-851
Open Access | Times Cited: 99
MicroRNAs in Alzheimer’s Disease: Function and Potential Applications as Diagnostic Biomarkers
Wei Wei, Zhiyong Wang, Lina Ma, et al.
Frontiers in Molecular Neuroscience (2020) Vol. 13
Open Access | Times Cited: 86
A Systematic Review of MicroRNA Expression as Biomarker of Late-Onset Alzheimer’s Disease
Soraya Herrera-Espejo, Borja Santos-Zorrozúa, Paula Álvarez‐González, et al.
Molecular Neurobiology (2019) Vol. 56, Iss. 12, pp. 8376-8391
Closed Access | Times Cited: 80
Machine Learning to Detect Alzheimer’s Disease from Circulating Non-Coding RNAs
Nicole Ludwig, Tobias Fehlmann, Fabian Kern, et al.
Genomics Proteomics & Bioinformatics (2019) Vol. 17, Iss. 4, pp. 430-440
Open Access | Times Cited: 77
The neurobiology of non-coding RNAs and Alzheimer’s disease pathogenesis: Pathways, mechanisms and translational opportunities
Elisabetta Lauretti, Konrad Dabrowski, Domenico Praticò
Ageing Research Reviews (2021) Vol. 71, pp. 101425-101425
Open Access | Times Cited: 74
Role of miRNAs in Neurodegeneration: From Disease Cause to Tools of Biomarker Discovery and Therapeutics
Bidisha Roy, Erica Lee, Teresa Li, et al.
Genes (2022) Vol. 13, Iss. 3, pp. 425-425
Open Access | Times Cited: 63
Exposure to a mixture of heavy metals induces cognitive impairment: Genes and microRNAs involved
Hai Duc Nguyen, Min‐Sun Kim
Toxicology (2022) Vol. 471, pp. 153164-153164
Closed Access | Times Cited: 56
MicroRNA Alteration, Application as Biomarkers, and Therapeutic Approaches in Neurodegenerative Diseases
T. P. Nhung Nguyen, Mandeep Kumar, Ernesto Fedele, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 4718-4718
Open Access | Times Cited: 55
miR-23b-3p rescues cognition in Alzheimer’s disease by reducing tau phosphorylation and apoptosis via GSK-3β signaling pathways
Hailun Jiang, Jianghong Liu, Shuilong Guo, et al.
Molecular Therapy — Nucleic Acids (2022) Vol. 28, pp. 539-557
Open Access | Times Cited: 48
Role of Epigenetic Modulation in Neurodegenerative Diseases: Implications of Phytochemical Interventions
Mani Iyer Prasanth, Bhagavathi Sundaram Sivamaruthi, Clerance Su Yee Cheong, et al.
Antioxidants (2024) Vol. 13, Iss. 5, pp. 606-606
Open Access | Times Cited: 14
Unveiling the Complex Role of Exosomes in Alzheimer’s Disease
Mingyue Sun, Zhuoyou Chen
Journal of Inflammation Research (2024) Vol. Volume 17, pp. 3921-3948
Open Access | Times Cited: 11
Identification of aberrant circulating miRNAs in Parkinson's disease plasma samples
Lei Chen, Junxiu Yang, Jinhui Lü, et al.
Brain and Behavior (2018) Vol. 8, Iss. 4
Open Access | Times Cited: 80
miRNA in Circulating Microvesicles as Biomarkers for Age-Related Cognitive Decline
Asha Rani, Andrew O’Shea, Lara Ianov, et al.
Frontiers in Aging Neuroscience (2017) Vol. 9
Open Access | Times Cited: 77
Page 1 - Next Page

Scroll to top